NDC 24979-0536-01
Guanfacine 3 mg/1 TABLET, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
24979-0536-01
Generic Name
Guanfacine
Brand Name
Guanfacine Extended-Release
Strength
3 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
Upsher-Smith Laboratories, LLC
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [ see Clinical Studies ( 14 ) ]. Guanfacine extended-release tablets are central alpha 2A -adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapyand as adjunctive therapy to stimulant medications ( 1 , 14 ) .
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Guanfacine Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Guanfacine NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 24979-0536-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).